Autopsy report · NCT05629767

Tracking of Lipid Lowering Therapy in Jordan

“Inadequate enrolling numbers of patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 year 1 month before it stopped.
• 1,000 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Jordan Collaborating Cardiology Group

Sponsor type

University, hospital or other

Conditions

Dyslipidemias; Atherosclerotic Cardiovascular Disease

Participants

1,000

Sites

2

Countries

Jordan

Trials that died the same way

• Ethanol Locks for the Treatment of Central Venous Line Infections
  “inability to enroll adequate number of patients” (91% match in meaning)
• Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery
  “Inadequate patient enrollment” (84% match in meaning)
• Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
  “no enough enrolled patients” (81% match in meaning)
• Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
  “Lack of patient enrollment” (80% match in meaning)
• Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
  “difficulty of enrolling patients” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.